Biotech
Goldman Sachs: Chinese Biotechnology Attracts Attention from Major Pharmaceutical Companies
Goldman Sachs reports that pharmaceutical companies are turning to Chinese biotechnology due to patent expirations.
ADARx Pharmaceuticals Completes Increased IPO of $446.3 Million
ADARx Pharmaceuticals raised $446.3 million in an increased IPO with a share price of $17.
Illumina Shares Reach 52-Week High of $231.82
Illumina shares reached a high of $231.82, showing growth in the biotechnology market.
OpenAI Funds Creation of Scientific Datasets Based on Failed Biotech Companies
OpenAI Foundation will create high-quality scientific datasets from biotechnology data with investments of nearly $1.1 trillion.